Causes of Pulmonary Hypertension

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer
Altitude and Hypoxia
Antiphospholipid Antibodies
Endothelial Dysfunction
Estrogen and Enzyme CYP1B1
Vascular Disease/Scleroderma


There are dozens of causes of pulmonary hypertension, ranging from genetics, medications or street drugs, connective tissue diseases (such as scleroderma), heart and lung diseases, and blood disorders.

Causes of Pulmonary Hypertension. Depending on the type, pulmonary hypertension can have many potential causes. MayoClinic.

Altitude and Hypoxia

Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension Two Randomized Controlled Trials. Hypoxia is a major cause of pulmonary hypertension in respiratory disease and at high altitude. Hypoxic pulmonary hypertension may be attenuated by iron supplementation and exacerbated by iron depletion. Thomas G. Smith, MBBS, DPhil. JAMA. (Also see Hypoxia, and Vitamins/Minerals)

Antiphospholipid Antibodies (APLA)

Clinical relevance of antiphospholipid antibodies in systemic sclerosis (SSc): A systematic review and meta–analysis. A strong relationship exists between aCL and aß2GPI of IgG/IgM isotype and SSc; patients positive for these antibodies are more likely to suffer from pulmonary hypertension, Raynaud's, thrombosis, and digital ulcers. PubMed, Semin Arthritis Rheum, 2017 Apr;46(5):615-624. (Also see Antiphospholipid Syndrome, Raynaud's and Digital Ulcers)

Endothelial Dysfunction

Endothelin and Systemic Scleroderma. Endothelin is a protein that helps to regulate contraction and relaxation of the smooth muscle found in the walls of blood vessels and internal organs (except the heart). An overproduction of endothelin, whether by illness or medication, can cause blood vessels to constrict and blood pressure to increase. In scleroderma, it can cause pulmonary arterial hypertension (PAH). ISN.

Endothelin and Systemic Scleroderma Endothelin Receptor Antagonists

Estrogen and Enzyme CYP1B1

The serotonin transporter (SERT) promotes a pathological estrogen metabolic pathway in pulmonary hypertension (PAH) via cytochrome P450 1B1. Increased intracellular serotonin caused by increased SERT expression may contribute to PAH pathobiology by dysregulation of estrogen metabolic pathways via increased CYP1B1 activity. PubMed, Pulm Circ, 2016 Mar;6(1):82-92.


Genes behind deadly heart condition found, scientists say. Scientists say they have identified genes that cause a deadly heart condition that can only be cured by transplants of the heart or lungs. BBC News, 04/15/2018.


Elevated Adipsin Levels are Associated with Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSC). Mechanistically, adipsin might represent a pathogenic link between adipocyte dysfunction and complement pathway activation, and play an important role in the pathogenesis of SSc–PAH. PubMed, Arthritis Rheumatol, 06/26/2017.

Medications that Cause Pulmonary Hypertension

Dasatinib-induced pulmonary arterial hypertension. Dasatinib-induced PAH usually seems to be reversible with the cessation of the drug, and sometimes with PAH-specific treatment strategies. PubMed, BR J Clin Pharmacol, 2018 Jan 15.

Vascular Disease and Scleroderma

Vascular Disease and Systemic Scleroderma. The vascular system is our circulatory system. It consists of all the vessels that carry blood and lymph through the body, to and from organs. Vessels include arteries, veins, and capillaries. Any condition that affects the vascular system, all of in part, is considered a vascular disease. ISN.

Vascular in Scleroderma
Types in Scleroderma
In Other CTDs
Personal Stories
Related Information
Go to Pulmonary Hypertension Diagnosis

Many thanks to our recent donors, Jack and Elizabeth Lewis. See ISN News for more donors. Click Here to Donate.


TOLL FREE HOTLINE, U.S. and Canada: 1-800-564-7099
Ask for our Free Info Packet by email or postal mail!

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses.

We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected] to request our Welcome email, report bad links, or update page content. Disclaimer. Privacy Policy.

The most important thing in the world to know about scleroderma is!